top of page
John Ripple serves as owner and Principal Consultant of Ripple Biotech, LCC, advising organizations on strategy, business development, and capital fundraising activities. He previously served as CEO of several venture-backed biotech companies including Exonics Therapeutics (acquired by Vertex); Virdante Pharmaceuticals (acquired by Momenta); and Syntonix Pharmaceuticals (acquired by Biogen).
Mr. Ripple also held positions in business development, medical device marketing, management consulting, and served as an entrepreneur-in-residence. Mr. Ripple received a BS in Mechanical Engineering from Bucknell University and an MBA from Harvard Business School.
bottom of page